Inositolized Phospholipids as Antiproliferative Agents
<strong>Background</strong><br>
Phospholipid analogues with high metabolic stability have been synthesized and proven to be successful as anti-proliferative agents. Due to negative side effects efforts have been made to synthesize phospholipids that are less cytotoxic.<br><br> <strong>Technology</strong><br> We offer a novel class of synthetic phospholipids, a method for preparing the phospholipids and their use for the treatment of proliferating diseases such as psoriasis and cancer. <br><br> The effectiveness of the synthetic ether phospholipid Ino-C2-PAF has been assessed in vitro and in vivo. In vitro studies with cancer cells and keratino-cytes revealed strong anti-proliferative and anti-inflammatory effects. Fur-thermore, in vivo studies in a mouse model of psoriasis (K5.hTGFß) proofed that Ino-C2-PAF has great therapeutic potential without having mutagenic or toxic side-effects. <br><br> Thus, these results position Ino-C2-PAF as an exciting new therapeutic agent for psoriasis.<br><br> <strong>Benefits</strong><br> <ul> <li>strong anti-proliferative and anti-inflammatory effects</li> <li>no mutagenic and no toxic side-effects</li> <li>wide spectrum of application including cancer and psoriasis</li> </ul><br> <strong>IP Rights</strong><br> Patent granted in US, JP, DE, CH, ES, FR, GB, IT (priority 11/2002); <br> Patent pending in CA<br><br> <strong>Patent Owner</strong><br> Charité – Universitätsmedizin Berlin
Further Information: PDF
ipal GmbH
Phone: +49 (0)30/2125-4820
Contact
Dr. Dirk Dantz
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…